The goal of this clinical trial is to see, if addition of chlorophyllin to neoadjuvant
Chemo-radiotherapy can reduce the gastro-intestinal/genitourinary/hematological toxicity
rates and improve the quality of life in patient's diagnosed with locally advanced rectal
cancer.
This is a randomized placebo control trial, wherein participants randomized to Chlorophyllin
arm will receive the drug of interest along with the standard treatment. Participants
randomized to other arm will receive placebo along with the standard treatment.
Researchers will compare the difference between the outcomes from both the arms and will also
observe the non-operative management success rates.